Algernon Pharmaceuticals Stock Technical Analysis

AGNPF Stock  USD 0.05  0  6.63%   
As of the 29th of November, Algernon Pharmaceuticals shows the mean deviation of 6.53, and Risk Adjusted Performance of 0.0087. Algernon Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Algernon Pharmaceuticals, which can be compared to its peers. Please confirm Algernon Pharmaceuticals mean deviation, information ratio, as well as the relationship between the Information Ratio and potential upside to decide if Algernon Pharmaceuticals is priced correctly, providing market reflects its regular price of 0.0549 per share. As Algernon Pharmaceuticals appears to be a penny stock we also recommend to validate its jensen alpha numbers.

Algernon Pharmaceuticals Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Algernon, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Algernon
  
Algernon Pharmaceuticals' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Algernon Pharmaceuticals technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
A focus of Algernon Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Algernon Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Algernon Pharmaceuticals Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Algernon Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Algernon Pharmaceuticals Trend Analysis

Use this graph to draw trend lines for Algernon Pharmaceuticals. You can use it to identify possible trend reversals for Algernon Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Algernon Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Algernon Pharmaceuticals Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Algernon Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of   0.0003  , which may suggest that Algernon Pharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.0, which is the sum of squared deviations for the predicted Algernon Pharmaceuticals price change compared to its average price change.

About Algernon Pharmaceuticals Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Algernon Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Algernon Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this otc stock, focuses on Algernon Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Algernon Pharmaceuticals. By analyzing Algernon Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Algernon Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Algernon Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.

Algernon Pharmaceuticals November 29, 2024 Technical Indicators

Most technical analysis of Algernon help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Algernon from various momentum indicators to cycle indicators. When you analyze Algernon charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Algernon Pharmaceuticals November 29, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Algernon stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Complementary Tools for Algernon OTC Stock analysis

When running Algernon Pharmaceuticals' price analysis, check to measure Algernon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Algernon Pharmaceuticals is operating at the current time. Most of Algernon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Algernon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Algernon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Algernon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Fundamental Analysis
View fundamental data based on most recent published financial statements
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Transaction History
View history of all your transactions and understand their impact on performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities